Results 14,621-14,640 of 49,836 for speaker:Stephen Donnelly

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: I propose to take Questions Nos. 635 and 705 together. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines and medical items, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. In line with the 2013 Act and the national framework agreed with industry, a company must submit an application to the HSE...

Written Answers — Department of Health: Health Services Staff (14 Feb 2023)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond directly to the Deputy, as soon as possible.

Written Answers — Department of Health: Health Services (14 Feb 2023)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: As part of Budget 2023, I announced €32.2 million in funding for Women’s Health Initiatives in 2023, to include dedicated funding for Cariban® (doxylamine/pyridoxine). The dedicated funding for Cariban® will help women who experience hyperemesis gravidarum, aa severe form of nausea and vomiting, during pregnancy. Hyperemesis gravidarum is expected to affect about 1% of...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: As part of Budget 2023, funding of €32.2 million was announced for Women’s Health Initiatives in 2023. This included dedicated funding for Cariban® (doxylamine/pyridoxine) to help women who experience hyperemesis gravidarum, a severe form of nausea and vomiting, during pregnancy. Hyperemesis gravidarum is expected to affect about 1% of the pregnant population. The Health...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: The National Centre for Pharmacoeconomics (NCPE) has responsibility for assessing evidence for comparative effectiveness and cost-effectiveness of technologies for use by patients in Ireland. This is done through assessment of evidence submitted by manufacturers and independent systematic review. The NCPE has conducted a Health Technology Assessment (HTA) on Evusheld. This is a standard...

Written Answers — Department of Health: Health Strategies (14 Feb 2023)

Stephen Donnelly: I wish to inform the Deputy that "future of the medically vulnerable to Covid-19" was not an agenda item at the Cabinet Committee for Health, and that I am committed to supporting those who are immunocompromised and immunosuppressed to fully participate in society as we emerge from the pandemic. As the Deputy will be aware, from the outset, our response to the pandemic has been supported by a...

Written Answers — Department of Health: Hospital Appointments Status (14 Feb 2023)

Stephen Donnelly: Under the Health Act 2004, the Health Service Executive (HSE) is required to manage and deliver, or arrange to be delivered on its behalf, health and personal social services. Section 6 of the HSE Governance Act 2013 bars the Minister for Health from directing the HSE to provide a treatment or a personal service to any individual or to confer eligibility on any individual. In relation to...

Written Answers — Department of Health: Medical Consent (14 Feb 2023)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Written Answers — Department of Health: Covid-19 Pandemic Supports (14 Feb 2023)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly.

Written Answers — Department of Health: Dental Services (14 Feb 2023)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Written Answers — Department of Health: Health Strategies (14 Feb 2023)

Stephen Donnelly: I am fully committed to supporting our population screening programmes which are a valuable part of our health service, enabling early treatment and care for many people, and improving the overall health of our population. Any decisions about screening will be made on the advice of the National Screening Advisory Committee (NSAC). This independent expert group considers and assesses...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: Under the Health (Pricing and Supply of Medical Goods) Act 2013, the HSE has statutory responsibility for pricing and reimbursement of new medicines. The HSE in its decision making considers the 5-year budget impact of each new medicine notwithstanding that the budget of the HSE is set on an annual basis. The year 1 costs of most medicines represent a fraction of the overall costs of those...

Written Answers — Department of Health: Primary Care Centres (14 Feb 2023)

Stephen Donnelly: A central objective of the Programme for Government is to deliver increased levels of integrated health care with service delivery reoriented towards general practice, primary care and community-based services to enable a “home first” approach. Primary Care Centres play an essential role in the delivery of that objective and significant progress has been made in the delivery of...

Written Answers — Department of Health: Primary Care Centres (14 Feb 2023)

Stephen Donnelly: As the Health Service Executive is responsible for the delivery of public healthcare infrastructure projects, I have asked the HSE to respond to you directly in relation to this matter.

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: The Medicinal Products (Prescription and Control of Supply) Regulations 2003, as amended sets out the system of control which applies to medicinal products, and identifies those products which may only be supplied on medical prescription. Naloxone is an active substance contained in a number of medicinal products authorised for use, in both single and combination active substance products...

Written Answers — Department of Health: Medicinal Products (14 Feb 2023)

Stephen Donnelly: As this is a service matter, I have asked the Health Service Executive to respond to the Deputy directly, as soon as possible.

Written Answers — Department of Health: Dental Services (14 Feb 2023)

Stephen Donnelly: I have consulted with the Dental Council on this matter. The Council have advised that the person in question has not yet made direct contact with the Dental Council. While the Dental Council does offer periods of adaption to applicants that don’t currently meet the necessary professional language competency standards, it is necessary for practical and for safety reasons to have...

Written Answers — Department of Health: Dental Services (14 Feb 2023)

Stephen Donnelly: The Dental Council has advised that it is continuing to accept and to process applications from dentists who have been granted either temporary or permanent protection by the State, via a new assessment process that the Council has developed and put in place for such cases. These complex cases are being managed by experienced registration officers, who continue to assess and manage the...

Written Answers — Department of Health: Nursing Homes (14 Feb 2023)

Stephen Donnelly: I propose to take Questions Nos. 673 and 674 together. Upon the raising of issues about how the State has approached legal challenges taken against it in relation to pre-2005 legacy nursing home charges, the Government moved quickly to establish the facts surrounding these issues, which go back many decades, by requesting the Attorney General to prepare a Report on the litigation management...